AU468465B2 - Tablet formulation - Google Patents

Tablet formulation

Info

Publication number
AU468465B2
AU468465B2 AU78170/75A AU7817075A AU468465B2 AU 468465 B2 AU468465 B2 AU 468465B2 AU 78170/75 A AU78170/75 A AU 78170/75A AU 7817075 A AU7817075 A AU 7817075A AU 468465 B2 AU468465 B2 AU 468465B2
Authority
AU
Australia
Prior art keywords
tablet formulation
formulation
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU78170/75A
Other languages
English (en)
Other versions
AU7817075A (en
Inventor
JOHN TORODE; DAVID HARDEN and JOHN SPENCE ALLAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU468465(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of AU7817075A publication Critical patent/AU7817075A/en
Publication of AU468465B2 publication Critical patent/AU468465B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
AU78170/75A 1974-02-14 1975-02-13 Tablet formulation Expired AU468465B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB6758/74 1974-02-14
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (2)

Publication Number Publication Date
AU7817075A AU7817075A (en) 1976-01-15
AU468465B2 true AU468465B2 (en) 1976-01-15

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78170/75A Expired AU468465B2 (en) 1974-02-14 1975-02-13 Tablet formulation

Country Status (32)

Country Link
JP (1) JPS5545043B2 (no)
AT (1) AT344915B (no)
AU (1) AU468465B2 (no)
BE (1) BE825496A (no)
CA (1) CA980688A (no)
CH (1) CH618432A5 (no)
CS (1) CS220306B2 (no)
CY (1) CY1052A (no)
DD (1) DD118228A5 (no)
DE (1) DE2506099C2 (no)
DK (1) DK143247C (no)
DO (1) DOP1979002763A (no)
ES (1) ES434688A1 (no)
FI (1) FI62219C (no)
FR (1) FR2260993B1 (no)
GB (1) GB1499672A (no)
GT (1) GT197960431A (no)
HK (1) HK23980A (no)
HU (1) HU171536B (no)
IE (1) IE40599B1 (no)
IL (1) IL46629A (no)
IN (1) IN141019B (no)
KE (1) KE3038A (no)
LU (1) LU71835A1 (no)
MC (1) MC1053A1 (no)
MY (1) MY8100054A (no)
NL (1) NL157501C (no)
NO (1) NO146043C (no)
PH (1) PH14575A (no)
SE (1) SE427898B (no)
ZA (1) ZA75930B (no)
ZM (1) ZM1875A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
DK143247B (da) 1981-08-03
NL157501C (nl) 1981-07-16
ZA75930B (en) 1976-01-28
NL157501B (nl) 1978-08-15
ATA108475A (de) 1977-12-15
KE3038A (en) 1980-04-25
NO146043B (no) 1982-04-13
ZM1875A1 (en) 1975-12-22
FR2260993B1 (no) 1978-06-30
CY1052A (en) 1980-08-01
AU7817075A (en) 1976-01-15
HK23980A (en) 1980-05-09
JPS5545043B2 (no) 1980-11-15
NO146043C (no) 1982-08-04
FI750398A (no) 1975-08-15
DE2506099C2 (de) 1983-11-03
AT344915B (de) 1978-08-25
DE2506099A1 (de) 1975-08-21
SE427898B (sv) 1983-05-24
MY8100054A (en) 1981-12-31
SE7501595L (no) 1975-08-15
NL7501680A (nl) 1975-08-18
ES434688A1 (es) 1977-04-01
DK52875A (no) 1975-10-06
FR2260993A1 (no) 1975-09-12
DD118228A5 (no) 1976-02-20
NO750467L (no) 1975-08-15
CS220306B2 (en) 1983-03-25
DOP1979002763A (es) 1987-06-18
GB1499672A (en) 1978-02-01
DK143247C (da) 1981-11-30
GT197960431A (es) 1981-05-05
IN141019B (no) 1977-01-08
CA980688A (en) 1975-12-30
JPS50116627A (no) 1975-09-12
CH618432A5 (en) 1980-07-31
IE40599B1 (en) 1979-07-04
IE40599L (en) 1975-08-14
PH14575A (en) 1981-09-24
FI62219C (fi) 1982-12-10
MC1053A1 (fr) 1976-02-20
IL46629A (en) 1977-07-31
HU171536B (hu) 1978-01-28
FI62219B (fi) 1982-08-31
LU71835A1 (no) 1975-06-24
BE825496A (fr) 1975-05-29
IL46629A0 (en) 1975-05-22

Similar Documents

Publication Publication Date Title
AU498975B2 (en) Denture cleanser tablet
AU497611B2 (en) Solid pharmaceutical formulation
AU487061B2 (en) Pharmaceutical compositions
AU467292B2 (en) Eye-bush
CA980688A (en) Tablet formulation
AU469472B2 (en) Tablet formulation
CA1034409A (en) Stop tablet assembly
CA1028617A (en) Iodophor formulation
AU495948B2 (en) Tablet formulation
ZM2976A1 (en) Tablet formulation
AU494543B2 (en) Pharmaceutical formulations
AU1110876A (en) Tablet formulation
CA1026415A (en) Pharmaceutical cabinet
AU492255B2 (en) Pharmaceutical compositions
AU8506875A (en) Pharmaceutical formulations
AU484632B2 (en) Aryloxyphenylpropylamines
AU487605B2 (en) Bulbholder
AU485075B2 (en) 2-nitroimidazoles
AU468625B2 (en) Wire-connector
AU475114B2 (en) Arylalkylsulphoxides
AU482293B2 (en) 7-methoxycephalosporins
AU482405B2 (en) Seco-prostaglandins
AU482524B2 (en) Pyridoindoles
AU485931B2 (en) Triazine-diones
AU484806B2 (en) Benzopyran-3-carbonitriles